Table 4.
Grouped level precision | Count | Overall (%) | 95% CI | Female (%) | Male (%) | P value | Median age |
Dermatological | 505 | 20.2 | 18.6 to 21.8 | 19.2 | 21.1 | 0.234* | 3.7 |
Oral | 272 | 10.9 | 9.7 to 12.1 | 8.1 | 13.4 | <0.001* | 4.3 |
Gastrointestinal/abdominal | 238 | 9.5 | 8.4 to 10.7 | 10.2 | 9.1 | 0.334* | 4.0 |
Ocular | 182 | 7.3 | 6.3 to 8.3 | 6.7 | 7.9 | 0.264* | 5.0 |
Parasitic | 178 | 7.1 | 6.1 to 8.2 | 6.7 | 7.6 | 0.401* | 4.2 |
Behavioural | 130 | 5.2 | 4.4 to 6.1 | 4.7 | 5.8 | 0.222* | 4.1 |
Trauma | 99 | 4.0 | 3.2 to 4.8 | 3.8 | 3.8 | 0.964* | 2.0 |
Respiratory | 93 | 3.7 | 3.0 to 4.5 | 3.3 | 4.1 | 0.259* | 3.4 |
Overweight/obesity | 92 | 3.7 | 3.0 to 4.5 | 4.4 | 3.2 | 0.100* | 3.4 |
Neurological | 74 | 3.0 | 2.3 to 3.7 | 3.6 | 2.5 | 0.098* | 4.4 |
Iatrogenic | 64 | 2.6 | 2.0 to 3.2 | 2.6 | 2.6 | 0.992* | 2.4 |
Mass-associated | 54 | 2.2 | 1.6 to 2.8 | 2.2 | 2.2 | 0.961* | 5.8 |
Weight loss/underweight | 51 | 2.0 | 1.5 to 2.7 | 2.3 | 1.7 | 0.250* | 4.9 |
Abscess | 47 | 1.9 | 1.4 to 2.5 | 1.9 | 1.9 | 0.965* | 4.8 |
Renal/urinary | 45 | 1.8 | 1.3 to 2.4 | 2.4 | 1.4 | 0.057* | 4.2 |
Musculoskeletal | 43 | 1.7 | 1.2 to 2.3 | 1.9 | 1.6 | 0.491* | 5.9 |
Auditory | 25 | 1.0 | 0.6 to 1.5 | 0.5 | 1.4 | 0.027* | 5.5 |
Infection | 19 | 0.8 | 0.5 to 1.2 | 1.0 | 0.6 | 0.295* | 2.2 |
Cardiovascular | 16 | 0.6 | 0.4 to 1.0 | 0.9 | 0.5 | 0.183* | 5.5 |
Neoplasia | 14 | 0.6 | 0.3 to 0.9 | 0.4 | 0.7 | 0.440* | 8.6 |
Reproductive | 6 | 0.2 | 0.1 to 0.5 | 0.5 | 0.1 | 0.100† | 2.9 |
Hepatic | 4 | 0.2 | 0.1 to 0.4 | 0.3 | 0.1 | 0.339† | 2.5 |
Soft tissue | 2 | 0.1 | 0.0 to 0.3 | 0.0 | 0.2 | 0.503† | 5.6 |
Congenital | 1 | 0.0 | 0.0 to 0.2 | 0.1 | 0.0 | 0.460† | 1.0 |
The P value reflects testing of the prevalence difference between females and males using the chi-squared test or Fisher’s exact test as indicated.
*Chi-squared test.
†Fisher’s exact test.
CI, confidence interval.